TABLE 4.

Percentage of patients experiencing clinically meaningful impairments (as defined in Methods) on each scale at the last visit

	Treated	Untreated	p
HFMSE (n = 44)	25%	9.5%	0.3
RULM (n = 72)	50%	22.9%	0.033
6MWT (n = 17)	75%	57%	0.85
ALSFRS‐R (n = 42)	25.7%	0%	0.005
EK2 (n = 31)	80%	22.7%	<0.001 *

Abbreviations: ALSFRS‐R, Amyotrophic Lateral Sclerosis Functional Scale Revised; EK2, Egen Klassifikation 2; HFMSE, Hammersmith Functional Motor Scale Expanded; RULM, Revised Upper Limb Module; 6MWT, 6‐min walk test.

^* p < 0.001.